Announcing expansion of capabilities to provide customers with a broader range of DNA synthesis solutions, allowing IDT to complement and extend its market position in minimum residual disease (MRD) and multi-cancer early detection (MCED) research to support high-diversity assays Builds on nearly 40 years of synthesis experience to give customers rapid turnaround of high-diversity oligonucleotides and a […]
The FOSS BactoScan™ 5, a rapid method for testing total bacteria count in raw milk, is now approved by MicroVal in Europe and NCIMS/FDA in the United States. Here is what the approvals cover – and what they mean for central milk testing laboratories, dairies, and producers. The National Conference on Interstate Milk Shipments (NCIMS), […]
SAN JOSE, Calif. — Complete Genomics, a U.S.-based provider of end-to-end DNA sequencing platforms, reagents and software, today announced the appointment of entrepreneur, investor and film producer Lauren Selig to its board of directors. Selig is the founder of Shake and Bake Productions and leads an investment fund focused on companies across artificial intelligence, space, biotechnology, media and other […]
Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb’s Next Phase of Growth DURHAM, N.C. — BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb’s Board of Directors and as Chair of […]
Appointment strengthens Element’s board as the company continues to advance the future of precision medicine and AI-enabled drug discovery; executive promotions reflect growing maturity of the company SAN DIEGO, CA — Element Biosciences, Inc. today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten brings more than 35 years of leadership […]
Amsbio has launched a range of synthetic cell mimic products that eliminate the variability, fragility, and operational inefficiency inherent in traditional flow cytometry biological and polystyrene bead controls. Researchers in pharmaceutical companies, biotechnology firms, CRO’s, clinical diagnostics and academic centres have long sought access to mass-produced cell mimics that contain rare biomarkers and are stable over the long […]
The Board of Directors of BICO Group AB today announces the appointment of Anders Fogelberg, currently Chief Commercial Officer, as President and CEO, effective September 1, 2026. The Board of Directors have, in a constructive dialogue together with the current President and CEO, Maria Forss, concluded that the time is right for a leadership change. […]
Uppsala, Sweden – Navinci Diagnostics AB today announces that the company has initiated a collaboration with BrainZell to explore the use of Navinci’s in situ Proximity Ligation Assay technology in human brain organoid models to support relevant studies of biology and drug response. The collaboration aims to evaluate how functional spatial readouts can be applied […]
Purpose-engineered cell-like controls deliver improved positive/negative separation, broad species compatibility, and a liquid, non-biohazardous ready-to-use format EMERYVILLE, Calif. — Slingshot Bio, Inc., a leader in precision cell mimic controls for flow cytometry, today announced the commercial launch of ViaComp® Ultra Amine, a next-generation compensation control designed for amine-reactive viability dyes and fluorophore-conjugated antibody panels in […]
Cognitive biomarker assays inform safety and efficacy decisions by measuring network potentiation and synaptic plasticity Advances the emerging field of organoid intelligence for drug development applications NEW ORLEANS — 28bio today launched CNS-3D Plasticity Organoids, enabling human functional endpoints of learning and memory before drug candidates enter clinical testing. Attrition in neurodegeneration remains among the highest […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
